A Trial of Levodopa in Angelman Syndrome
Children's Hospital Medical Center, Cincinnati
Baylor College of Medicine

      This study is designed to determine whether levodopa will lead to an improvement in the
      development and tremor in children with Angelman syndrome (AS).

      It has been suggested that levodopa, a medication that is usually used to treat Parkinson
      disease in adults, may help children with AS in their overall development and reduce the
      tremor that some of them have.

      If levodopa is found to be beneficial for children with AS, this could lead to a new
      treatment for AS.

      Funding Source - FDA-OOPD
    
Drug